207 related articles for article (PubMed ID: 16493254)
1. Early diagnosis and predictors of malignancy of adnexal masses.
Murta EF; Nomelini RS
Curr Opin Obstet Gynecol; 2006 Feb; 18(1):14-9. PubMed ID: 16493254
[TBL] [Abstract][Full Text] [Related]
2. Inclusion of CA-125 does not improve mathematical models developed to distinguish between benign and malignant adnexal tumors.
Timmerman D; Van Calster B; Jurkovic D; Valentin L; Testa AC; Bernard JP; Van Holsbeke C; Van Huffel S; Vergote I; Bourne T
J Clin Oncol; 2007 Sep; 25(27):4194-200. PubMed ID: 17698805
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and management of adnexal masses.
Givens V; Mitchell GE; Harraway-Smith C; Reddy A; Maness DL
Am Fam Physician; 2009 Oct; 80(8):815-20. PubMed ID: 19835343
[TBL] [Abstract][Full Text] [Related]
4. Peri- and post-menopausal incidental adnexal masses and the risk of sporadic ovarian malignancy: new insights and clinical management.
Pérez-López FR; Chedraui P; Troyano-Luque JM
Gynecol Endocrinol; 2010 Sep; 26(9):631-43. PubMed ID: 20500106
[TBL] [Abstract][Full Text] [Related]
5. [Adnexal masses management: a prospective multicentric observational study].
Huchon C; Bats AS; Bensaïd C; Junger M; Nos C; Chatellier G; Lécuru F
Gynecol Obstet Fertil; 2008 Nov; 36(11):1084-90. PubMed ID: 18964176
[TBL] [Abstract][Full Text] [Related]
6. External validation of mathematical models to distinguish between benign and malignant adnexal tumors: a multicenter study by the International Ovarian Tumor Analysis Group.
Van Holsbeke C; Van Calster B; Valentin L; Testa AC; Ferrazzi E; Dimou I; Lu C; Moerman P; Van Huffel S; Vergote I; Timmerman D;
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4440-7. PubMed ID: 17671128
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the detection of ovarian cancer: a review.
Blend MJ; Ostrowski GJ
J Am Osteopath Assoc; 1994 Apr; 94(4):305-18. PubMed ID: 8026999
[TBL] [Abstract][Full Text] [Related]
8. Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group.
Timmerman D; Testa AC; Bourne T; Ferrazzi E; Ameye L; Konstantinovic ML; Van Calster B; Collins WP; Vergote I; Van Huffel S; Valentin L;
J Clin Oncol; 2005 Dec; 23(34):8794-801. PubMed ID: 16314639
[TBL] [Abstract][Full Text] [Related]
9. Role of laparoscopy in the diagnosis and treatment of adnexal masses.
Leng JH; Lang JH; Zhang JJ; Feng FZ; Liu ZF; Sun DW; Zhu L; Zhao XY
Chin Med J (Engl); 2006 Feb; 119(3):202-6. PubMed ID: 16537005
[TBL] [Abstract][Full Text] [Related]
10. Human epididymis protein 4 offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal women.
Holcomb K; Vucetic Z; Miller MC; Knapp RC
Am J Obstet Gynecol; 2011 Oct; 205(4):358.e1-6. PubMed ID: 21722869
[TBL] [Abstract][Full Text] [Related]
11. Distinguishing the benign and malignant adnexal mass: an external validation of prognostic models.
Mol BW; Boll D; De Kanter M; Heintz AP; Sijmons EA; Oei SG; Bal H; Brölmann HA
Gynecol Oncol; 2001 Feb; 80(2):162-7. PubMed ID: 11161854
[TBL] [Abstract][Full Text] [Related]
12. Ovarian malignancy in breast cancer patients with an adnexal mass.
Simpkins F; Zahurak M; Armstrong D; Grumbine F; Bristow R
Obstet Gynecol; 2005 Mar; 105(3):507-13. PubMed ID: 15738016
[TBL] [Abstract][Full Text] [Related]
13. Adnexal masses in the premenopausal patient.
Hall TR; Randall TC
Clin Obstet Gynecol; 2015 Mar; 58(1):47-52. PubMed ID: 25608252
[TBL] [Abstract][Full Text] [Related]
14. Sonographic accuracy in the diagnosis of ovarian masses.
Benacerraf BR; Finkler NJ; Wojciechowski C; Knapp RC
J Reprod Med; 1990 May; 35(5):491-5. PubMed ID: 2191131
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance evaluation of adnexal masses.
Guerra A; Cunha TM; Félix A
Acta Radiol; 2008 Jul; 49(6):700-9. PubMed ID: 18568564
[TBL] [Abstract][Full Text] [Related]
16. Adnexal mass in the postmenopausal patient.
Rauh-Hain JA; Melamed A; Buskwofie A; Schorge JO
Clin Obstet Gynecol; 2015 Mar; 58(1):53-65. PubMed ID: 25565080
[TBL] [Abstract][Full Text] [Related]
17. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.
Moore RG; Brown AK; Miller MC; Skates S; Allard WJ; Verch T; Steinhoff M; Messerlian G; DiSilvestro P; Granai CO; Bast RC
Gynecol Oncol; 2008 Feb; 108(2):402-8. PubMed ID: 18061248
[TBL] [Abstract][Full Text] [Related]
18. Adnexal masses in pregnancy.
Schwartz N; Timor-Tritsch IE; Wang E
Clin Obstet Gynecol; 2009 Dec; 52(4):570-85. PubMed ID: 20393410
[TBL] [Abstract][Full Text] [Related]
19. Introduction of new Tumor Marker Age Score in clinical practice: Validity evaluation for differentiation benign from malignant adnexal masses.
Ladjević IL; Terzić M; Ladjević N; Dotlić J; Pilić I; Bila J; Knezević N; Milenković S; Maricić S; Arsenović N; Brndusić N; Nikolić B
Acta Chir Iugosl; 2012; 59(3):49-56. PubMed ID: 23654006
[TBL] [Abstract][Full Text] [Related]
20. Screening and detection of ovarian cancer.
Breedlove G; Busenhart C
J Midwifery Womens Health; 2005; 50(1):51-4. PubMed ID: 15637515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
